<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>Annals of Internal Medicine: Endocarditis Topic Collection</title>
    <link>http://annals.org/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Tue, 05 May 2009 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 09 Apr 2013 13:46:58 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@annals.org</managingEditor>
    <webMaster>webmaster@annals.org</webMaster>
    <item>
      <title>Health Care–Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition</title>
      <link>http://annals.org/article.aspx?articleID=744467</link>
      <pubDate>Tue, 05 May 2009 00:00:00 GMT</pubDate>
      <author>Benito N, Miró JM, de Lazzari E, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Background:&lt;/div&gt;The clinical profile and outcome of nosocomial and non-nosocomial health careâ€“associated native valve endocarditis are not well defined.&lt;div class="boxTitle"&gt;Objective:&lt;/div&gt;To compare the characteristics and outcomes of community-associated and nosocomial and non-nosocomial health careâ€“associated native valve endocarditis.&lt;div class="boxTitle"&gt;Design:&lt;/div&gt;Prospective cohort study.&lt;div class="boxTitle"&gt;Setting:&lt;/div&gt;61 hospitals in 28 countries.&lt;div class="boxTitle"&gt;Patients:&lt;/div&gt;Patients with definite native valve endocarditis and no history of injection drug use who were enrolled in the ICE-PCS (International Collaboration on Endocarditis Prospective Cohort Study) from June 2000 to August 2005.&lt;div class="boxTitle"&gt;Measurements:&lt;/div&gt;Clinical and echocardiographic findings, microbiology, complications, and mortality.&lt;div class="boxTitle"&gt;Results:&lt;/div&gt;Health careâ€“associated native valve endocarditis was present in 557 (34%) of 1622 patients (303 with nosocomial infection [54%] and 254 with non-nosocomial infection [46%]). &lt;span style="font-style:italic;"&gt;Staphylococcus aureus&lt;/span&gt; was the most common cause of health careâ€“associated infection (nosocomial, 47%; non-nosocomial, 42%; &lt;span style="font-style:italic;"&gt;P&lt;/span&gt;Â = 0.30); a high proportion of patients had methicillin-resistant &lt;span style="font-style:italic;"&gt;S. aureus&lt;/span&gt; (nosocomial, 57%; non-nosocomial, 41%; &lt;span style="font-style:italic;"&gt;P&lt;/span&gt;Â = 0.014). Fewer patients with health careâ€“associated native valve endocarditis had cardiac surgery (41% vs. 51% of community-associated cases; &lt;span style="font-style:italic;"&gt;P&lt;/span&gt;Â &lt; 0.001), but more of the former patients died (25% vs. 13%; &lt;span style="font-style:italic;"&gt;P&lt;/span&gt;Â &lt; 0.001). Multivariable analysis confirmed greater mortality associated with health careâ€“associated native valve endocarditis (incidence risk ratio, 1.28 [95% CI, 1.02 to 1.59]).&lt;div class="boxTitle"&gt;Limitations:&lt;/div&gt;Patients were treated at hospitals with cardiac surgery programs. The results may not be generalizable to patients receiving care in other types of facilities or to those with prosthetic valves or past injection drug use.&lt;div class="boxTitle"&gt;Conclusion:&lt;/div&gt;More than one third of cases of native valve endocarditis in nonâ€“injection drug users involve contact with health care, and non-nosocomial infection is common, especially in the United States. Clinicians should recognize that outpatients with extensive out-of-hospital health care contacts who develop endocarditis have clinical characteristics and outcomes similar to those of patients with nosocomial infection.&lt;div class="boxTitle"&gt;Primary Funding Source:&lt;/div&gt;None.&lt;/span&gt;</description>
      <guid>http://annals.org/article.aspx?articleID=744467</guid>
    </item>
  </channel>
</rss>